{"id":678,"date":"2021-07-15T16:14:11","date_gmt":"2021-07-15T23:14:11","guid":{"rendered":"https:\/\/admin.acceleratingscience.com\/ask-a-scientist\/?p=678"},"modified":"2022-03-03T09:17:10","modified_gmt":"2022-03-03T17:17:10","slug":"fda-eua-covid-19-flu-a-flu-b","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/","title":{"rendered":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu"},"content":{"rendered":"<p>The Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV-2, influenza A and influenza B viruses in nasopharyngeal and nasal swabs. To help meet the demand for <a href=\"https:\/\/www.thermofisher.com\/us\/en\/home\/clinical\/clinical-genomics\/pathogen-detection-solutions\/covid-19-sars-cov-2\/influenza-a-b-multiplex.html\">respiratory testing during the overlap of covid-19 and the flu season<\/a>, the TaqPath COVID-19, Flu A, Flu B Combo Kit is <a href=\"https:\/\/www.thermofisher.com\/us\/en\/home\/clinical\/clinical-genomics\/pathogen-detection-solutions\/covid-19-sars-cov-2\/influenza-a-b-multiplex.html\">approved for emergency use<\/a> and available for purchase.<\/p>\n<p>With the overlap of flu season and the novel coronavirus pandemic, it is vital that clinical and public health labs have access to a single test that can simultaneously detect RNA from multiple respiratory viruses. The TaqPath COVID-19, Flu A, Flu B Combo Kit can help labs expand their existing COVID-19 testing menu for respiratory samples while supporting low operational costs and workflow simplicity. The combo kit includes Applied Biosystems Pathogen Interpretive Software to automatically convert genetic analysis data into a readable report, helping reduce risk of user interpretation error.<\/p>\n<p>\u201cWe knew that this season\u2019s surge in COVID-19 infections could coincide with cases of influenza and RSV, so we worked quickly to develop a PCR-based diagnostic kit for detecting and differentiating these illnesses simultaneously,\u201d said Mark Smedley, President of Genetic Sciences for Thermo Fisher. \u201cOur kit provides laboratories with the ability to diagnose and monitor\u00a0the spread of COVID-19 and similar illnesses,\u00a0which may require different patient management, including quarantining measures.\u201d\u00a0\u00a0We are striving to supply the tests you need to meet respiratory testing demand during flu season.<\/p>\n<p><em>The TaqPath COVID-19, Flu A, Flu B Combo Kit has not been FDA cleared or approved and is only authorized for the duration of the EUA.<\/em><\/p>\n<h2 style=\"font-size: 125%\">Next Steps<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.thermofisher.com\/us\/en\/home\/global\/forms\/life-science\/covid19-influenza-poster.html\">Get information on workflow and performance<\/a> of the TaqPath COVID-19, Flu A, Flu B Combo Kit summarized in a poster<\/li>\n<li><a href=\"https:\/\/www.thermofisher.com\/us\/en\/home\/global\/forms\/clinical\/taqpath-covid-19-flu-eua.html\">Request a quote<\/a> for the TaqPath COVID-19, Flu A, Flu B Combo Kit<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV-2, influenza A and influenza B viruses in nasopharyngeal and nasal swabs. To help meet the demand for respiratory testing during the overlap of covid-19 and the flu season, the<\/p>\n","protected":false},"author":1597,"featured_media":15800,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[9],"tags":[215,96,22,104,105,26],"division":[],"class_list":{"0":"post-678","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-product-news","8":"tag-clinical-testing","9":"tag-content-literature","10":"tag-covid-19","11":"tag-influenza","12":"tag-rsv","13":"tag-sars-cov-2","14":"entry"},"_selected_authors":"","_selected_reviewers":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu - Clinical Conversations<\/title>\n<meta name=\"description\" content=\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu\" \/>\n<meta property=\"og:description\" content=\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Conversations\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thermofisher\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-15T23:14:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-03T17:17:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"310\" \/>\n\t<meta property=\"og:image:height\" content=\"274\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"peterfriebe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:site\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"peterfriebe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/\"},\"author\":{\"name\":\"peterfriebe\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/#\\\/schema\\\/person\\\/44b3a96ed8ab5e107d2d7198a4344417\"},\"headline\":\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu\",\"datePublished\":\"2021-07-15T23:14:11+00:00\",\"dateModified\":\"2022-03-03T17:17:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/\"},\"wordCount\":335,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/wp-content\\\/uploads\\\/sites\\\/18\\\/2021\\\/07\\\/ComboKitEUA-310x274-1.jpg\",\"keywords\":[\"Clinical testing\",\"content-Literature\",\"COVID-19\",\"Influenza\",\"RSV\",\"sars-cov-2\"],\"articleSection\":[\"Product news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/\",\"name\":\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu - Clinical Conversations\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/wp-content\\\/uploads\\\/sites\\\/18\\\/2021\\\/07\\\/ComboKitEUA-310x274-1.jpg\",\"datePublished\":\"2021-07-15T23:14:11+00:00\",\"dateModified\":\"2022-03-03T17:17:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/#\\\/schema\\\/person\\\/44b3a96ed8ab5e107d2d7198a4344417\"},\"description\":\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/wp-content\\\/uploads\\\/sites\\\/18\\\/2021\\\/07\\\/ComboKitEUA-310x274-1.jpg\",\"contentUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/wp-content\\\/uploads\\\/sites\\\/18\\\/2021\\\/07\\\/ComboKitEUA-310x274-1.jpg\",\"width\":310,\"height\":274,\"caption\":\"TaqPath covid-19, flu a, flu b combo kit\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/fda-eua-covid-19-flu-a-flu-b\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/#website\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/\",\"name\":\"Clinical Conversations\",\"description\":\"Molecular and antibody testing content for clinical lab professionals and clinicians\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/clinical-conversations\\\/#\\\/schema\\\/person\\\/44b3a96ed8ab5e107d2d7198a4344417\",\"name\":\"peterfriebe\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/author\\\/peterfriebe\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu - Clinical Conversations","description":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/","og_locale":"en_US","og_type":"article","og_title":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu","og_description":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.","og_url":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/","og_site_name":"Clinical Conversations","article_publisher":"https:\/\/www.facebook.com\/thermofisher","article_published_time":"2021-07-15T23:14:11+00:00","article_modified_time":"2022-03-03T17:17:10+00:00","og_image":[{"width":310,"height":274,"url":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg","type":"image\/jpeg"}],"author":"peterfriebe","twitter_card":"summary_large_image","twitter_creator":"@thermofisher","twitter_site":"@thermofisher","twitter_misc":{"Written by":"peterfriebe","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#article","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/"},"author":{"name":"peterfriebe","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/#\/schema\/person\/44b3a96ed8ab5e107d2d7198a4344417"},"headline":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu","datePublished":"2021-07-15T23:14:11+00:00","dateModified":"2022-03-03T17:17:10+00:00","mainEntityOfPage":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/"},"wordCount":335,"commentCount":0,"image":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg","keywords":["Clinical testing","content-Literature","COVID-19","Influenza","RSV","sars-cov-2"],"articleSection":["Product news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/","url":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/","name":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu - Clinical Conversations","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#primaryimage"},"image":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg","datePublished":"2021-07-15T23:14:11+00:00","dateModified":"2022-03-03T17:17:10+00:00","author":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/#\/schema\/person\/44b3a96ed8ab5e107d2d7198a4344417"},"description":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit just in time for flu season.","breadcrumb":{"@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#primaryimage","url":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg","contentUrl":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg","width":310,"height":274,"caption":"TaqPath covid-19, flu a, flu b combo kit"},{"@type":"BreadcrumbList","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/fda-eua-covid-19-flu-a-flu-b\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/"},{"@type":"ListItem","position":2,"name":"FDA grants emergency use authorization for new COVID-19, Flu A, Flu B, Combo Kit\u2026 just in time for the return of the flu"}]},{"@type":"WebSite","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/#website","url":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/","name":"Clinical Conversations","description":"Molecular and antibody testing content for clinical lab professionals and clinicians","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/admin.acceleratingscience.com\/clinical-conversations\/#\/schema\/person\/44b3a96ed8ab5e107d2d7198a4344417","name":"peterfriebe","url":"https:\/\/admin.acceleratingscience.com\/author\/peterfriebe\/"}]}},"taxonomy_info":{"category":[{"value":9,"label":"Product news"}],"post_tag":[{"value":215,"label":"Clinical testing"},{"value":96,"label":"content-Literature"},{"value":22,"label":"COVID-19"},{"value":104,"label":"Influenza"},{"value":105,"label":"RSV"},{"value":26,"label":"sars-cov-2"}]},"featured_image_src_large":["https:\/\/admin.acceleratingscience.com\/clinical-conversations\/wp-content\/uploads\/sites\/18\/2021\/07\/ComboKitEUA-310x274-1.jpg",310,274,false],"author_info":{"display_name":"peterfriebe","author_link":"https:\/\/admin.acceleratingscience.com\/author\/peterfriebe\/"},"comment_info":0,"category_info":[{"term_id":9,"name":"Product news","slug":"product-news","term_group":0,"term_taxonomy_id":9,"taxonomy":"category","description":"","parent":0,"count":19,"filter":"raw","meta":[],"cat_ID":9,"category_count":19,"category_description":"","cat_name":"Product news","category_nicename":"product-news","category_parent":0}],"tag_info":[{"term_id":215,"name":"Clinical testing","slug":"clinical-testing","term_group":0,"term_taxonomy_id":215,"taxonomy":"post_tag","description":"","parent":0,"count":25,"filter":"raw","meta":[]},{"term_id":96,"name":"content-Literature","slug":"content-literature","term_group":0,"term_taxonomy_id":96,"taxonomy":"post_tag","description":"","parent":0,"count":8,"filter":"raw","meta":[]},{"term_id":22,"name":"COVID-19","slug":"covid-19","term_group":0,"term_taxonomy_id":22,"taxonomy":"post_tag","description":"","parent":0,"count":102,"filter":"raw","meta":[]},{"term_id":104,"name":"Influenza","slug":"influenza","term_group":0,"term_taxonomy_id":104,"taxonomy":"post_tag","description":"","parent":0,"count":19,"filter":"raw","meta":[]},{"term_id":105,"name":"RSV","slug":"rsv","term_group":0,"term_taxonomy_id":105,"taxonomy":"post_tag","description":"","parent":0,"count":4,"filter":"raw","meta":[]},{"term_id":26,"name":"sars-cov-2","slug":"sars-cov-2","term_group":0,"term_taxonomy_id":26,"taxonomy":"post_tag","description":"","parent":0,"count":73,"filter":"raw","meta":[]}],"_links":{"self":[{"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/posts\/678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/users\/1597"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/comments?post=678"}],"version-history":[{"count":0,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/posts\/678\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/media\/15800"}],"wp:attachment":[{"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/media?parent=678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/categories?post=678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/tags?post=678"},{"taxonomy":"division","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/clinical-conversations\/wp-json\/wp\/v2\/division?post=678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}